Clinical and prognostic role of the plasma level of stimulating growth factor in patients with miscellaneous cardiovascular pathology

Іванов, В. П.; Mezhiievska, IA; Maslovskyi, V.Yu.

doi:10.25040/aml2019.01.082

AML

2019

DOI: 10.25040/aml2019.01.082

|View full text |Cite

Clinical and prognostic role of the plasma level of stimulating growth factor in patients with miscellaneous cardiovascular pathology

В. П. Іванов¹,

IA Mezhiievska²,

V.Yu. Maslovskyi³

Abstract: Ìåòà. Âèçíà÷èòè êë³í³êî-ïðî´íîñòè÷íó ðîëü ïëàçìîâîãî ð³âíÿ ñòèìóëþþ÷îãî ôàêòîðó ðîñòó ïðè ð³çí³é ñåðöåâî-ñóäèíí³é ïàòîëî´³¿. Ìàòåð³àë ³ ìåòîäè. Ïðîàíàë³çîâàíî äaeåðåëà ë³òåðàòóðè, ó ÿêèõ âèñâ³òëåíà êë³í³êî-ïðî´íîñòè÷íà ðîëü ïëàçìîâîãî ð³âíÿ ñòèìóëþþ÷îãî ôàêòîðó ðîñòó ïðè ñåðöåâî-ñóäèíí³é ïàòîëî´³¿ Ðåçóëüòàòè é îáãîâîðåííÿ. Àíàë³ç ñó÷àñíî¿ ë³òåðàòóðè çàñâ³ä÷óº ï³äâèùåíó óâàãó â÷åíèõ äî çíà÷åííÿ ³ ðîë³ ð³çíèõ íå³íâàç³éíèõ á³îìàðêåð³â, òàêèõ ÿê òðî-ïîí³í ², íàòð³éóðåòè÷íèé ïåïòèä, ãàëåêòèí-3, ñòè-ìóëþþ÷èé ôàêòîð … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2022

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 23 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

The Level of Growth Stimulating Factor Expressed by Gene 2 and Troponin I in the Blood Plasma of Nstemi Patients Depending on Different Clinical Characteristics

Maslovskyi

Mezhiievska

2022

Wiad Lek

View full text Add to dashboard Cite

The aim of the study is to evaluate the relationship between ST2 and Troponin I with various clinical and instrumental parameters. Materials and methods: We examined 200 patients with NSTEMI aged 38 to 80 years, who were urgently hospitalized in the Vinnytsya Regional Clinical Center of Cardiovascular Pathology. All patients underwent laboratory testing of ST2 and Troponin I levels in plasma by enzyme-linked immunosorbent assay on the first day of hospitalization before coronary angiography. Results: Elevations in ST2 levels were significantly higher in patients with acute heart failure (Killip III) and the presence of acute arrhythmias, diabetes mellitus, and smoking. The increase in Troponin I was associated primarily with the nature of changes in the ECG, stratification on the GRACE score and the presence of concomitant arterial hypertension. Conclusions: Determination of ST2 and Troponin I before coronary angiography makes it possible to predict the course of NSTEMI and make appropriate therapeutic corrections to prevent complications.

show abstract

The Level of Growth Stimulating Factor Expressed by Gene 2 and Troponin I in the Blood Plasma of Nstemi Patients Depending on Different Clinical Characteristics

Maslovskyi

Mezhiievska

2022

Wiad Lek

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Clinical and prognostic role of the plasma level of stimulating growth factor in patients with miscellaneous cardiovascular pathology

Cited by 1 publication

References 23 publications

The Level of Growth Stimulating Factor Expressed by Gene 2 and Troponin I in the Blood Plasma of Nstemi Patients Depending on Different Clinical Characteristics

The Level of Growth Stimulating Factor Expressed by Gene 2 and Troponin I in the Blood Plasma of Nstemi Patients Depending on Different Clinical Characteristics

Contact Info

Product

Resources

About